Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120247

Author :

Publish date : 2026-03-10 21:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Senator to Investigate FDA Rejections of Rare Disease Drugs

FDA Reverses Stance on Leucovorin for Autism

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

Related Posts

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

FDA Reverses Stance on Leucovorin for Autism

Some Cancers May Be Slightly Elevated in Women Who’ve Had Fertility Treatment

FDA OKs Leucovorin for Rare Genetic Disorder, but Not Autism

Extended Dupilumab Dosing Maintains Efficacy in Nasal Polyps

Superagers Have Different Brains; Suicidality and Seizures; Brain Prize Winners

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

Senator to Investigate FDA Rejections of Rare Disease Drugs

FDA Reverses Stance on Leucovorin for Autism

Some Cancers May Be Slightly Elevated in Women Who’ve Had Fertility Treatment

FDA OKs Leucovorin for Rare Genetic Disorder, but Not Autism

Extended Dupilumab Dosing Maintains Efficacy in Nasal Polyps

Superagers Have Different Brains; Suicidality and Seizures; Brain Prize Winners

Doctors Raise Their Voices Against AMR

Categories

Archives